Ryoko Sakai

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 10

Top Topics

Rheumatoid Arthritis

Cardiovascular Events

Health Insurance

Top Venues

International journal of rheumatic diseases

Rheumatology and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Ryoko Sakai, Eiichi Tanaka, Eisuke Inoue, Masayoshi Harigai
Increased risk of cardiovascular events under the treatments with Janus kinase inhibitors versus biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a retrospective longitudinal population-based study using the Japanese health insurance database. RMD open 10 (2) (2024)
Masayoshi Harigai, Eiichi Tanaka, Eisuke Inoue, Ryoko Sakai, Naohiro Sugitani, Shigeyuki Toyoizumi, Naonobu Sugiyama, Hisashi Yamanaka
Incidence of Malignancies and the Association with Biological Disease-Modifying Antirheumatic Drugs in Japanese Patients with Rheumatoid Arthritis: A Time-Dependent Analysis from the IORRA Patient Registry. Rheumatology and therapy (2024)
Ryoko Sakai, Eiichi Tanaka, Eisuke Inoue, Masayoshi Harigai
Increased risk of cardiovascular events under the treatments with Janus kinase inhibitors versus biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a retrospective longitudinal population-based study using the Japanese health insurance database. RMD open 10 (2) (2024)
Ryoko Sakai, Eiichi Tanaka, Eisuke Inoue, Masayoshi Harigai
Increased risk of cardiovascular events under the treatments with Janus kinase inhibitors versus biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a retrospective longitudinal population-based study using the Japanese health insurance database. RMD open 10 (2) (2024)
Suguru Honda, Ryoko Sakai, Eisuke Inoue, Masako Majima, Naoko Konda, Hideto Takada, Mari Kihara, Nobuyuki Yajima, Toshihiro Nanki, Kazuhiko Yamamoto, Tsutomu Takeuchi, Masayoshi Harigai
Association of methotrexate use and lymphoproliferative disorder in patients with rheumatoid arthritis: Results from a Japanese multi-institutional retrospective study. Modern rheumatology (2021)
Ryoko Sakai, Suguru Honda, Eiichi Tanaka, Masako Majima, Naoko Konda, Hideto Takada, Masayoshi Harigai
The risk of hospitalized infection in patients with systemic lupus erythematosus treated with hydroxychloroquine. Lupus 29 (13) (2020)
Ayako Nakajima, Ryoko Sakai, Eisuke Inoue, Masayoshi Harigai
Prevalence of patients with rheumatoid arthritis and age-stratified trends in clinical characteristics and treatment, based on the National Database of Health Insurance Claims and Specific Health Checkups of Japan. International journal of rheumatic diseases 23 (12) (2020)
Ryoko Sakai, Soo Kyung Cho, Eun Jin Jang, Masayoshi Harigai, Yoon-Kyoung Sung
International descriptive study for comparison of treatment patterns in patients with knee osteoarthritis between Korea and Japan using claims data. International journal of rheumatic diseases 22 (11) (2019)
Ryoko Sakai, Eiichi Tanaka, Hirokazu Nishina, Masayoshi Suzuki, Hisashi Yamanaka, Masayoshi Harigai
Risk of opportunistic infections in patients with antineutrophil cytoplasmic antibody-associated vasculitis, using a Japanese health insurance database. International journal of rheumatic diseases 22 (11) (2019)
Ryoko Sakai, Shoko Kasai, Fumio Hirano, Sayoko Harada, Mari Kihara, Waka Yokoyama, Michi Tsutsumino, Kenji Nagasaka, Ryuji Koike, Hisashi Yamanaka, Nobuyuki Miyasaka, Masayoshi Harigai
No increased risk of herpes zoster in TNF inhibitor and non-TNF inhibitor users with rheumatoid arthritis: epidemiological study using the Japanese health insurance database. International journal of rheumatic diseases 21 (9) (2018)